Cargando…

Durability of initial antidiabetic monotherapy and subsequent treatment adjustment patterns among newly treated type 2 diabetes patients

BACKGROUND: As newly available antidiabetic drugs (ADs) are used more commonly as initial hypoglycemic choice for early stage diabetes patients, there is an urgent need to investigate how these agents may differ in treatment durability relative to metformin. This study aimed to investigate the incid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noh, Yoojin, Lee, Sukhyang, Shin, Sooyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130268/ https://www.ncbi.nlm.nih.gov/pubmed/30233191 http://dx.doi.org/10.2147/TCRM.S169964

Ejemplares similares

Impact of Statin Use on Dementia Incidence in Elderly Men and Women with Ischemic Heart Disease
por: Kim, Mi-Young, et al.
Publicado: (2020)

Evaluation of preventable adverse drug reactions by implementation of the nationwide network of prospective drug utilization review program in Korea
por: Lee, Jimin, et al.
Publicado: (2018)

Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients
por: Shin, Sooyoung, et al.
Publicado: (2014)

Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND)
por: Tajima, Atsushi, et al.
Publicado: (2022)

Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials
por: Shin, Sooyoung, et al.
Publicado: (2018)

Impact of statins on risk of new onset diabetes mellitus: a population-based cohort study using the Korean National Health Insurance claims database
por: Lee, Jimin, et al.
Publicado: (2016)

Correction: Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND)
Publicado: (2023)

Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database
por: Noh, Yoojin, et al.
Publicado: (2016)

Incident infection risks depending on oral antidiabetic exposure in insulin-treated type 2 diabetes patients
por: Park, Sanghwa, et al.
Publicado: (2023)

Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in Japan
por: Yabe, Daisuke, et al.
Publicado: (2020)

What Is the Optimal Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients?: The Practical Evidence of Antidiabetic Monotherapy Study
por: Choi, Ji Hun, et al.
Publicado: (2011)

Comparison of the Efficacy of Glimepiride, Metformin, and Rosiglitazone Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients: The Practical Evidence of Antidiabetic Monotherapy Study
por: Yoon, Kun Ho, et al.
Publicado: (2011)

Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Yoo, Soon-Jib, et al.
Publicado: (2021)

Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: An East Asian perspective
por: Ji, Linong, et al.
Publicado: (2020)

Durability of pneumatic dilation monotherapy in treatment-naive achalasia patients
por: Javed, Abid T., et al.
Publicado: (2019)

Dose adjustment of antidiabetic medications in chronic kidney disease
por: Snyder, Matthew Salvatore, et al.
Publicado: (2021)

Durable Disease-free Survival in a Patient with Metastatic Triple-negative Breast Cancer Treated with Olaparib Monotherapy
por: Wang, Xue, et al.
Publicado: (2022)

Use, Durability, and Risks for Discontinuation of Initial and Subsequent Biologics in a Large Pediatric-Onset IBD Cohort
por: Kaplan, Jess L., et al.
Publicado: (2023)

Durable and Complete Response to Herceptin Monotherapy in Patients with Metastatic Gastroesophageal Cancer
por: Swofford, Brenen P., et al.
Publicado: (2017)

Regulation of Adropin by Sitagliptin monotherapy in participants with newly diagnosed type 2 Diabetes
por: Wang, Qiu, et al.
Publicado: (2022)

Comparison of antidiabetic drugs added to sulfonylurea monotherapy in patients with type 2 diabetes mellitus: A network meta-analysis
por: Qian, Dan, et al.
Publicado: (2018)

The Change in HbA1c Associated with Initial Adherence and Subsequent Change in Adherence among Diabetes Patients Newly Initiating Metformin Therapy
por: Nichols, Gregory A., et al.
Publicado: (2016)

Antidiabetic Drug Prescription Pattern in Hospitalized Older Patients with Diabetes
por: Ardoino, Ilaria, et al.
Publicado: (2023)

Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy
por: Jerkins, Terri, et al.
Publicado: (2021)

Surfaces with Adjustable Features—Effective and Durable Materials for Water Desalination
por: Al-Gharabli, Samer, et al.
Publicado: (2021)

Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes
por: Liu, Jia, et al.
Publicado: (2017)

Durable Response to Venetoclax Monotherapy in Richter’s Syndrome: A Case Report and Review of Literature
por: Kollipara, Revathi, et al.
Publicado: (2019)

Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus
por: Jermendy, György, et al.
Publicado: (2012)

Disparities in Initial Oral Antidiabetic Medication Adherence Among Veterans with Incident Diabetes
por: Gatwood, Justin D., et al.
Publicado: (2018)

Comparative Efficacy and Safety of Antidiabetic Drug Regimens Added to Metformin Monotherapy in Patients with Type 2 Diabetes: A Network Meta-Analysis
por: Mearns, Elizabeth S., et al.
Publicado: (2015)

Lamotrigine monotherapy for newly diagnosed typical absence seizures in children()
por: Holmes, Gregory L., et al.
Publicado: (2008)

Prescribing patterns of antidiabetics in type 2 diabetes and factors affecting them
por: Allyhiani, Moayad, et al.
Publicado: (2022)

Comparative evaluation of incretin‐based antidiabetic medications and alternative therapies to be added to metformin in the case of monotherapy failure
por: Nauck, Michael A, et al.
Publicado: (2010)

Dual Therapy Appears Superior to Monotherapy for Low-Income Individuals With Newly Diagnosed Type 2 Diabetes
por: Vaughan, Elizabeth M., et al.
Publicado: (2017)

Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT)
por: Howden, Kaitlyn, et al.
Publicado: (2022)

Study of hospitalization and mortality in Korean diabetic patients using the diabetes complications severity index
por: Yoo, Hyunju, et al.
Publicado: (2020)

Efficacy of ipragliflozin as monotherapy or as add‐on therapy with other oral antidiabetic medications for treating type 2 diabetes in Japanese patients with inadequate glycemic control: A subgroup analysis based on patient characteristics
por: Osonoi, Takeshi, et al.
Publicado: (2017)

Comprehensive Trends and Patterns of Antihypertensive Prescriptions Using a Nationwide Claims Database in Korea
por: Jung, Minji, et al.
Publicado: (2020)

Effectiveness and tolerability of perampanel monotherapy in children with newly diagnosed focal epilepsy
por: Zhao, Fen, et al.
Publicado: (2023)

Long-Term Patterns of Antidiabetic Medication Use in Patients with Type 2 Diabetes
por: Xu, Yang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jjsv1pjh3g0hi3ohjbm1jcp4e9